Cáncer de Mama en la Población LGBTQIA+
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4511Palabras clave:
neoplasias de la mama, minorías sexuales y de género, prevención de enfermedadesResumen
El cáncer de mama es una preocupación global de salud pública, afectando a millones de personas cada año. Sin embargo, la experiencia de esta enfermedad puede ser particular para la población LGBTQIA+ que, muchas veces, enfrenta desafíos únicos con relación a la salud. Frente a la relevancia del asunto y a la falta de investigaciones y estudios sobre el cáncer de mama en la población LGBTQIA+, este artículo de opinión busca resaltar la importancia de un enfoque inclusivo en el tratamiento y en la prevención del cáncer de mama en esa comunidad, explorando las injusticias existentes y proponiendo estrategias concretas para promover una salud más equitativa, como las disparidades en la salud, los factores de riesgo específicos, los desafíos psicosociales, la promoción da concientización y de la educación, y la inclusión de esa población en estudios de investigación.
Descargas
Citas
Instituto Nacional de Câncer. Estimativa 2023: incidência do câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2022. [acesso 2023 nov 30]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf
Oliveira DAL. Políticas de saúde e diagnóstico precoce do câncer de mama no Brasil. Rev Enferm Digit Cuid Promoção da Saúde, 2019;4(1):46-50. doi: https://doi.org/10.5935/2446-5682.20190009 DOI: https://doi.org/10.5935/2446-5682.20190009
Howlader N, Noone AM, Krapcho M, et al, organizadores. SEER cancer statistics review, 1975-2018. Bethesda: Nacional Cancer Institute; 2018. [acesso 2023 nov 30]. Disponível em: https://seer.cancer.gov/archive/csr/1975_2018/index.html
Migowski A, Silva GA, Dias MBK, et al. Diretrizes para detecção precoce do câncer de mama no Brasil. II – Novas recomendações nacionais, principais evidências e controvérsias. Cad. Saúde Pública. 2018;34(6):e00074817. doi: https://doi.org/10.1590/0102-311X00074817https://doi.org/10.1590/0102-311X00074817 DOI: https://doi.org/10.1590/0102-311x00074817
International Agency for Research on Cancer. Breast cancer screening [Internet]. v. 15. Lion: IARC; 2016. [acesso 2023 nov 30]. Disponível em: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016
Hasset MJ, Somerfield MR, Baker ER, et. al. Management of Male Breast Cancer. Am Soc Clin Oncol. 2020;38(6):1849-63. Disponível em: https://ascopubs.org/doi/full/10.1200/JCO.19.03120 DOI: https://doi.org/10.1200/JCO.19.03120
Gibson AW, Radix AE, Maingi S, et al. Cancer care in lesbian, gay, bisexual, transgender and queer populations. Future Oncol. 2017;13(15):1333-44. DOI: https://doi.org/10.2217/fon-2017-0482
Puechl AM, Russel K, Gray BA. Care and cancer screening of the transgender population. J Womens Health 2019; 28(6):761-768. DOI: https://doi.org/10.1089/jwh.2018.6945
Stone JP, Hartley RL. Temple-Oberle C. Breast cancer in transgender patients: A systematic review. Part 2: Female to Male. Eur J Surg Oncol. 2018;44(10):1463-8. doi: https://doi.org/10.1016/j.ejso.2018.06.021 DOI: https://doi.org/10.1016/j.ejso.2018.06.021
Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: A systematic review. part 1: male to female. Eur J Surg Oncol. 2018;44(10):1455-62. doi: https://doi.org/10.1016/j.ejso.2018.06.035 DOI: https://doi.org/10.1016/j.ejso.2018.06.035
Spizzirri G, Eufrásio R, Lima MCP, et al. Proporção de pessoas identificadas como transexuais e não binárias no Brasil. Sci Rep. 2021;11(1):2240. doi: https://doi.org/10.1038/s41598-021-81411-4 DOI: https://doi.org/10.1038/s41598-021-81411-4
Barrett J. Gender dysphoria: assessment and management for non-specialists. BMJ. 2017;30:357:j2866. doi: https://doi.org/10.1136/bmj.j2866 DOI: https://doi.org/10.1136/bmj.j2866
Sant’Ana RSE. Strategies for inclusive care to LGBTQIAP+ people with cancer. Rev Bras Cancerol. 2023;69(2):e-163671. DOI: https://doi.org/10.32635/2176-9745.RBC.2023v69n2.3671
Braun H, Nash R, Tangpricha V, et al. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev. 2017;39(1):93-107. doi: https://doi.org/10.1093/epirev/mxw003 DOI: https://doi.org/10.1093/epirev/mxw003
Price S, McManus J, Barrett J. The transgender population: improving awareness for gynaecologists and their role in the provision of care. The Obstet Gynaecol. 2019;21(1):11-20. doi: https://doi.org/10.1111/tog.12521 DOI: https://doi.org/10.1111/tog.12521
Blok CJ, Wiepjes CM, Nota NM, et. al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the netherlands british medical journal. BMJ. 2019;365:1652. doi: https://doi.org/10.1136/bmj.l1652 DOI: https://doi.org/10.1136/bmj.l1652
Patel H, Arruarana V, Yao L, et al. Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Endocrine. 2020;68(1):6-15. DOI: https://doi.org/10.1007/s12020-020-02197-5
Domene FM, Silva JL, Toma TS, et al. Saúde da população LGBTQIA+: revisão de escopo rápida da produção científica brasileira. Ciênc saúde coletiva. 2022; 27(10):3835-48. DOI: https://doi.org/10.1590/1413-812320222710.07122022en
Charkhchi P, Schabath MB, Carlos RC. Modifiers of cancer screening prevention among sexual and gender minorities in the behavioral risk factor surveillance system. J Am Coll Radiol; 2019;16(4PtB):607-20. doi: https://doi.org/10.1016/j.jacr.2019.02.042 DOI: https://doi.org/10.1016/j.jacr.2019.02.042
Chapman-Pratt ML, Ward AR. Provider recommendations are associated with cancer screening of transgender and gender-nonconforming people: a cross-sectional urban survery. Transgend Health; 2020;5(2):80-5. doi: Disponível em: https://doi.org/10.1089/trgh.2019.0083 DOI: https://doi.org/10.1089/trgh.2019.0083
Bazzi AR, Whorms DS, King DS, et al. Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health. 2015;105(11):2356-8. DOI: https://doi.org/10.2105/AJPH.2015.302851
Deutsch MB, Radix A, Wesp L. Breast cancer screening, management, and a review of case study literature in transgender populations. Semin Reprod Med. 2017;35(5):434-41. doi: https://doi.org/10.1055/s-0037-1606103 DOI: https://doi.org/10.1055/s-0037-1606103
Calas MJG, Dantas RFA, Ciscotto CB, et al. Integrative review on breast cancer screening in the transgender population: what do we know? Mastology 2022;32:e20210051. doi: https://doi.org/10.29289/2594539420210051 DOI: https://doi.org/10.29289/2594539420210051
Corso G, Gandini S, D'Ecclesiis O, et al. Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis. Eur J Cancer Prev. 2023;32(3):207-14. DOI: https://doi.org/10.1097/CEJ.0000000000000784
Nikolić D, Granić M, Ivanović N, et al. Breast cancer and its impact in male transsexuals. Breast Cancer Res Treat. 2018;171(3):565-9. doi:
https://doi.org/10.1007/s10549-018-4875-y DOI: https://doi.org/10.1007/s10549-018-4875-y
Stewart T, Lee YA, Damiano EA. Do transgender and gender diverse individuals receive adequate gynecologic care? an analysis of a rural academic center. Transgend Health. 2020;5(1):50-8. doi: https://doi.org/10.1089/trgh.2019.0037 DOI: https://doi.org/10.1089/trgh.2019.0037
Labanca T, Mañero I, Pannunzio M. Transgender patients: considerations for routine gynecologic care and cancer screening. Inter J Gynec Cancer. 2020;30(12):1990-6. doi: https://doi.org/10.1136/ijgc-2020-001860 DOI: https://doi.org/10.1136/ijgc-2020-001860
Mendonça WJR. Breast cancer screening in transgenders: an integrative literature review. Res Soc Devel. 2022;11(17):e245111738953. doi: https://doi.org/10.33448/rsd-v11i17.38953 DOI: https://doi.org/10.33448/rsd-v11i17.38953
Schmidt E, Rizzolo D. Disease screening and prevention for transgender and gender-diverse adults. JAAPA. 2017;30(10):11-6. doi: https://doi.org/10.1097/01.JAA.0000524709.87224.57 DOI: https://doi.org/10.1097/01.JAA.0000524709.87224.57
Narayan A, Lebron-Zapata L, Morris E. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey. Breast Cancer Res Treat. 2017;166(3):875-9. doi: https://doi.org/10.1007/s10549-017-4461-8 DOI: https://doi.org/10.1007/s10549-017-4461-8
Fredriksen-Goldsen KI. The aging and health report: disparities and resilience among lesbian, gay, bisexual, and transgender older adults. Public Policy Aging Rep. 2011;21(3):3-7. DOI: https://doi.org/10.1093/ppar/21.3.3
Eismann J, Heng YJ, Fleischmann-Rose K, et al. Interdisciplinary management of transgender individuals at risk for breast cancer: case reports and review of the literature. Clinical Breast Cancer. 2019;19(1):e-12-9. doi: https://doi.org/10.1016/j.clbc.2018.11.007 DOI: https://doi.org/10.1016/j.clbc.2018.11.007
Kiran T, Davie S, Singh D, et.al. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician. 2019;65(1):e30-7.
Gkiouleka A, Wong G, Sowden Sarah S. el al. Reducing health inequalities through general practice. The Lancet Public Health. 2023;8(8):e583. doi: https://doi.org/10.1016/S2468-2667(23)00093-2 DOI: https://doi.org/10.1016/S2468-2667(23)00093-2
Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-85. http://dx.doi.org/10.21037/tau-20-954 DOI: https://doi.org/10.21037/tau-20-954
Publicado
Cómo citar
Número
Sección
Licencia
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
